Found 8 hits of ic50 for monomerid = 50311931 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Tyrosine-protein kinase Lck
(Homo sapiens (Human)) | BDBM50311931
(CHEMBL1076469 | N-(3-(1-(6-(4-(dimethylamino)butyl...)Show SMILES CN(C)CCCCNc1cc(ncn1)-n1c(Nc2cc(NC(=O)c3cccc(c3)C(F)(F)F)ccc2C)nc2ccccc12 Show InChI InChI=1S/C32H33F3N8O/c1-21-13-14-24(39-30(44)22-9-8-10-23(17-22)32(33,34)35)18-26(21)41-31-40-25-11-4-5-12-27(25)43(31)29-19-28(37-20-38-29)36-15-6-7-16-42(2)3/h4-5,8-14,17-20H,6-7,15-16H2,1-3H3,(H,39,44)(H,40,41)(H,36,37,38) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of LCK |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase HCK
(Homo sapiens (Human)) | BDBM50311931
(CHEMBL1076469 | N-(3-(1-(6-(4-(dimethylamino)butyl...)Show SMILES CN(C)CCCCNc1cc(ncn1)-n1c(Nc2cc(NC(=O)c3cccc(c3)C(F)(F)F)ccc2C)nc2ccccc12 Show InChI InChI=1S/C32H33F3N8O/c1-21-13-14-24(39-30(44)22-9-8-10-23(17-22)32(33,34)35)18-26(21)41-31-40-25-11-4-5-12-27(25)43(31)29-19-28(37-20-38-29)36-15-6-7-16-42(2)3/h4-5,8-14,17-20H,6-7,15-16H2,1-3H3,(H,39,44)(H,40,41)(H,36,37,38) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 65 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of HCK |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase Lck
(Homo sapiens (Human)) | BDBM50311931
(CHEMBL1076469 | N-(3-(1-(6-(4-(dimethylamino)butyl...)Show SMILES CN(C)CCCCNc1cc(ncn1)-n1c(Nc2cc(NC(=O)c3cccc(c3)C(F)(F)F)ccc2C)nc2ccccc12 Show InChI InChI=1S/C32H33F3N8O/c1-21-13-14-24(39-30(44)22-9-8-10-23(17-22)32(33,34)35)18-26(21)41-31-40-25-11-4-5-12-27(25)43(31)29-19-28(37-20-38-29)36-15-6-7-16-42(2)3/h4-5,8-14,17-20H,6-7,15-16H2,1-3H3,(H,39,44)(H,40,41)(H,36,37,38) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 108 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused LCK expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Proto-oncogene tyrosine-protein kinase Src
(Homo sapiens (Human)) | BDBM50311931
(CHEMBL1076469 | N-(3-(1-(6-(4-(dimethylamino)butyl...)Show SMILES CN(C)CCCCNc1cc(ncn1)-n1c(Nc2cc(NC(=O)c3cccc(c3)C(F)(F)F)ccc2C)nc2ccccc12 Show InChI InChI=1S/C32H33F3N8O/c1-21-13-14-24(39-30(44)22-9-8-10-23(17-22)32(33,34)35)18-26(21)41-31-40-25-11-4-5-12-27(25)43(31)29-19-28(37-20-38-29)36-15-6-7-16-42(2)3/h4-5,8-14,17-20H,6-7,15-16H2,1-3H3,(H,39,44)(H,40,41)(H,36,37,38) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 139 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of SRC |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase Lyn
(Homo sapiens (Human)) | BDBM50311931
(CHEMBL1076469 | N-(3-(1-(6-(4-(dimethylamino)butyl...)Show SMILES CN(C)CCCCNc1cc(ncn1)-n1c(Nc2cc(NC(=O)c3cccc(c3)C(F)(F)F)ccc2C)nc2ccccc12 Show InChI InChI=1S/C32H33F3N8O/c1-21-13-14-24(39-30(44)22-9-8-10-23(17-22)32(33,34)35)18-26(21)41-31-40-25-11-4-5-12-27(25)43(31)29-19-28(37-20-38-29)36-15-6-7-16-42(2)3/h4-5,8-14,17-20H,6-7,15-16H2,1-3H3,(H,39,44)(H,40,41)(H,36,37,38) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 399 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused LYN expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Proto-oncogene tyrosine-protein kinase Src
(Homo sapiens (Human)) | BDBM50311931
(CHEMBL1076469 | N-(3-(1-(6-(4-(dimethylamino)butyl...)Show SMILES CN(C)CCCCNc1cc(ncn1)-n1c(Nc2cc(NC(=O)c3cccc(c3)C(F)(F)F)ccc2C)nc2ccccc12 Show InChI InChI=1S/C32H33F3N8O/c1-21-13-14-24(39-30(44)22-9-8-10-23(17-22)32(33,34)35)18-26(21)41-31-40-25-11-4-5-12-27(25)43(31)29-19-28(37-20-38-29)36-15-6-7-16-42(2)3/h4-5,8-14,17-20H,6-7,15-16H2,1-3H3,(H,39,44)(H,40,41)(H,36,37,38) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 1.21E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused SRC expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50311931
(CHEMBL1076469 | N-(3-(1-(6-(4-(dimethylamino)butyl...)Show SMILES CN(C)CCCCNc1cc(ncn1)-n1c(Nc2cc(NC(=O)c3cccc(c3)C(F)(F)F)ccc2C)nc2ccccc12 Show InChI InChI=1S/C32H33F3N8O/c1-21-13-14-24(39-30(44)22-9-8-10-23(17-22)32(33,34)35)18-26(21)41-31-40-25-11-4-5-12-27(25)43(31)29-19-28(37-20-38-29)36-15-6-7-16-42(2)3/h4-5,8-14,17-20H,6-7,15-16H2,1-3H3,(H,39,44)(H,40,41)(H,36,37,38) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 1.37E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused KDR expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Insulin receptor
(Homo sapiens (Human)) | BDBM50311931
(CHEMBL1076469 | N-(3-(1-(6-(4-(dimethylamino)butyl...)Show SMILES CN(C)CCCCNc1cc(ncn1)-n1c(Nc2cc(NC(=O)c3cccc(c3)C(F)(F)F)ccc2C)nc2ccccc12 Show InChI InChI=1S/C32H33F3N8O/c1-21-13-14-24(39-30(44)22-9-8-10-23(17-22)32(33,34)35)18-26(21)41-31-40-25-11-4-5-12-27(25)43(31)29-19-28(37-20-38-29)36-15-6-7-16-42(2)3/h4-5,8-14,17-20H,6-7,15-16H2,1-3H3,(H,39,44)(H,40,41)(H,36,37,38) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 3.11E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused InsR expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |